- Home
- MASI
MASI
Masimo Corporation
as 12-27-2024 9:54am EST
Masimo Corp is a global technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies.
| Founded: | 1989 | Country: | United States |
| Employees: | N/A | City: | IRVINE |
| Market Cap: | 9.3B | IPO Year: | 2007 |
| Target Price: | $175.67 | AVG Volume (30 days): | 449.1K |
| Analyst Decision: | Buy | Number of Analysts: | 7 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 1.45 | EPS Growth: | -11.35 |
| 52 Week Low/High: | $101.61 - $180.97 | Next Earning Date: | 02-25-2025 |
| Revenue: | $2,042,600,000 | Revenue Growth: | -3.48% |
| Revenue Growth (this year): | 3.85% | Revenue Growth (next year): | 2.26% |
Latest Masimo Corporation News
MASI Breaking Stock News: Dive into MASI Ticker-Specific Updates for Smart Investing
Argus Research
4 days ago
MASI: Lowering target price to $176.00
Zacks
7 days ago
The Zacks Analyst Blog Highlights Veracyte, Omnicell, Masimo and Abbott Laboratories
Zacks
8 days ago
4 Healthcare Technology Innovators to Invest in Before the New Year
Simply Wall St.
9 days ago
Those who invested in Masimo (NASDAQ:MASI) a year ago are up 50%
Argus Research
10 days ago
MASI: What does Argus have to say about MASI?
Zacks
11 days ago
3 Medical Instruments Industry Stocks to Buy on the GenAI Wave
MedTech Dive
16 days ago
Masimo lays off 75 employees in California
Argus Research
17 days ago
MASI: What does Argus have to say about MASI?
Compare MASI vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "MASI Masimo Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.